跳至主要内容
临床试验/ACTRN12620001364965
ACTRN12620001364965尚未招募4 期

Short-term effects of micronised progesterone on sleep quality in transfeminine individuals: arandomised, placebo-controlled cross-over trial

Austin Health0 个研究点目标入组 38 人开始时间: 2020年12月18日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
Austin Health
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
Female

入选标准

  • Transfeminine individuals aged 18-70 years.

排除标准

  • 1. Contraindications to micronised progesterone.
  • 2. Sunflower seed allergy.
  • 3. Known, suspected, or history of breast cancer.
  • 4. Active deep vein thrombosis, pulmonary embolism or history of these conditions.
  • 5. Active arterial thromboembolic disease or history of these conditions.
  • 6. Known liver dysfunction or disease.
  • 7. Recreational drug use, alcohol dependence, known HIV/AIDS or any disease that is
  • likely lead to serious illness or death within the study period.
  • 8. Inability to understand sufficient English to provide informed consent or participate in

研究者

发起方
Austin Health

相似试验

Micronised progesterone for sleep in transgender wome | 临床试验